Gerrit‐Jan Weverling

1.4k citations

20 papers · 1.1k indexed · h-index 15

Co-authors: Nicole H. T. M. Dukers–Muijrers Jaap Goudsmit John de Wit Roel A. Coutinho Maria Prins Marco J. Bruno Djuna L. Cahen Paul Fockens
Topics: HIV Research and Treatment (10 papers)HIV/AIDS Research and Interventions (8 papers)HIV/AIDS drug development and treatment (6 papers)
Cited by: Virology Infectious Diseases Epidemiology
Journals: The Lancet Gastroenterology American Journal of Epidemiology
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Gerrit‐Jan Weverling

20 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gerrit‐Jan Weverling

Since Specialization

Citations

This map shows the geographic impact of Gerrit‐Jan Weverling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit‐Jan Weverling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit‐Jan Weverling more than expected).

Fields of papers citing papers by Gerrit‐Jan Weverling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit‐Jan Weverling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit‐Jan Weverling. The network helps show where Gerrit‐Jan Weverling may publish in the future.

Co-authorship network of co-authors of Gerrit‐Jan Weverling

This figure shows the co-authorship network connecting the top 25 collaborators of Gerrit‐Jan Weverling. A scholar is included among the top collaborators of Gerrit‐Jan Weverling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerrit‐Jan Weverling. Gerrit‐Jan Weverling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endoscopic Drainage of Pancreatic Pseudocysts: Long-Term Outcome and Procedural Factors Associated with Safe and Successful Treatment 2005 ·Endoscopy ·Djuna L. Cahen,E RAUWS,Paul Fockens,Gerrit‐Jan Weverling,K. Huibregtse,Marco J. Bruno	157
2	Adiponectin and glucose production in patients infected with Plasmodium falciparum 2004 ·Metabolism ·Regje M. E. Blümer,Huynh Van Thien,An F.C. Ruiter,Gerrit‐Jan Weverling,(unknown),Erik Endert,Piet A. Kager,Hans P. Sauerwein	14
3	Free fatty acids increase hepatic glycogen content in obese males 2004 ·Metabolism ·Gideon Allick,F. Sprangers,Gerrit‐Jan Weverling,Mariëtte T. Ackermans,(unknown),Johannes A. Romijn,Erik Endert,Peter H. Bisschop,H. P. Sauerwein	12
4	FFAs are not involved in regulation of gluconeogenesis and glycogenolysis in adults with uncomplicated P. falciparum malaria 2004 ·American Journal of Physiology-Endocrinology and Metabolism ·Huynh Van Thien,Gerrit‐Jan Weverling,Mariëtte T. Ackermans,Nguyen Canh Hung,Erik Endert,Piet A. Kager,H.P. Sauerwein	11
5	Gluconeogenesis and fasting in cerebral malaria. 2004 ·PubMed ·Huynh Van Thien,Mariëtte T. Ackermans,Gerrit‐Jan Weverling,(unknown),Erik Endert,Piet A. Kager,H.P. Sauerwein	5
6	AIDS Vaccines That Allow HIV-1 to Infect and Escape Immunologic Control 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown),Johannes A. Bogaards,Gerrit‐Jan Weverling,Maarten C. Boerlijst,Jaap Goudsmit	14
7	Influence of prolonged starvation on glucose kinetics in pregnant patients infected with Plasmodium falciparum 2003 ·Clinical Nutrition ·Huynh Van Thien,Mariëtte T. Ackermans,Gerrit‐Jan Weverling,(unknown),Erik Endert,Piet A. Kager,H. P. Sauerwein	12
8	Legionnaires’ Disease at a Dutch Flower Show: Prognostic Factors and Impact of Therapy 2002 ·Emerging infectious diseases ·Kamilla D. Lettinga,Annelies Verbon,Gerrit‐Jan Weverling,Joop Schellekens,Jeroen W. Den Boer,Ed P. F. Yzerman,(unknown),Wim Boersma,R J van Ketel,Jan M. Prins,Peter Speelman	70
9	Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort 2002 ·AIDS ·Jeanne P. Dieleman,Mariëlle Jambroes,Inge C. Gyssens,Miriam Sturkenboom,Bruno H. Stricker,W. Mulder,Frank de Wolf,Gerrit‐Jan Weverling,Joep M. A. Lange,Peter Reiss,Kees Brinkman	67
10	Estimating the efficacy of interventions to prevent mother‐to‐child transmission of HIV in breast‐feeding populations: development of a consensus methodology 2001 ·Statistics in Medicine ·Ahmadou Alioum,François Dabis,L. Dequae-Merchadou,(unknown),Michael G. Hudgens,James P. Hughes,John M. Karon,Valériane Leroy,Marie‐Louise Newell,Barbra A. Richardson,Gerrit‐Jan Weverling	46
11	Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection 2001 ·AIDS ·Nicole H. T. M. Dukers–Muijrers,Jaap Goudsmit,John de Wit,Maria Prins,Gerrit‐Jan Weverling,Roel A. Coutinho	205
12	Cerebrospinal fluid β2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor α receptors before and after treatment with lamivudine plus zidovudine or stavudine 2000 ·Journal of Neuroimmunology ·Roelien H. Enting,Norbert A. Foudraine,Joep M. A. Lange,Suzanne Jurriaans,Tom van der Poll,Gerrit‐Jan Weverling,Peter Portegies	23
13	A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients 2000 ·AIDS ·Kiat Ruxrungtham,Eugène Kroon,Chaiwat Ungsedhapand,(unknown),Sasiwimol Ubolyam,Supranee Buranapraditkun,Remko van Leeuwen,Gerrit‐Jan Weverling,Chaiyos Kunanusont,Joep M. A. Lange,David A. Cooper,Praphan Phanuphak	23
14	Risk Factors for Human Herpesvirus 8 Seropositivity and Seroconversion in a Cohort of Homosexula Men 2000 ·American Journal of Epidemiology ·Nicole H. T. M. Dukers–Muijrers,Neil Renwick,M. Prins,Ronald B. Geskus,Thomas F. Schulz,Gerrit‐Jan Weverling,R A Coutinho,Jaap Goudsmit	119
15	Global view of helicobacter pylori associated gastritis 2000 ·Gastroenterology ·Yi Liu,Cyriel Y. Ponsioen,Gerrit‐Jan Weverling,Shudong Xiao,Guido N.J. Tytgat,Fiebo J. ten Kate	2
16	HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial 1997 ·The Lancet ·Françoise Brun‐Vézinet,Charles A. Boucher,Clive Loveday,Diane Descamps,(unknown),Jacques Izopet,Don Jeffries,Steve Kaye,(unknown),Andrew Nunn,Rob Schuurman,Jean‐Marie Seigneurin,Catherine Tamalet,Richard S. Tedder,Jonathan Weber,Gerrit‐Jan Weverling	96
17	Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma 1996 ·Journal of Clinical Microbiology ·Rob Schuurman,Diane Descamps,Gerrit‐Jan Weverling,Steve Kaye,Jolanda M.G.H. Tijnagel,Ian Williams,Remko van Leeuwen,Richard S. Tedder,Charles A. Boucher,F Brun-Vézinet,Clive Loveday	93
18	Distinct Changes in HIV Type 1 RNA versus p24 Antigen Levels in Serum during Short-Term Zidovudine Therapy in Asymptomatic Individuals with and without Progression to AIDS 1995 ·AIDS Research and Human Retroviruses ·Suzanne Jurriaans,Gerrit‐Jan Weverling,Jaap Goudsmit,Jossy van den Boogaard,Melina G.H.E. den Brok,Dianne van Strijp,J Lange,M. Koot,Bob van Gemen	20
19	Zidovudine and Interferon- Combination Therapy versus Zidovudine Monotherapy in Subjects with Symptomatic Human Immunodeficiency Virus Type 1 Infection 1994 ·The Journal of Infectious Diseases ·P. H. J. Frissen,Marc van der Valk,Chris H.H. ten Napel,H Weigel,Gerrit Schreij,(unknown),P.P. Koopmans,Andy I. M. Hoepelman,Josien B. de Boer,Gerrit‐Jan Weverling,(unknown),Pauline M. Dowd,Frank Miedema,(unknown),Charles A. Boucher,J. M. A. Lange	28
20	Evaluation of Different Tests for the Serodiagnosis of Tuberculosis and the Use of Likelihood Ratios in Serology 1993 ·American Review of Respiratory Disease ·Annelies Verbon,Gerrit‐Jan Weverling,Sjoukje Kuijper,Peter Speelman,H M Jansen,A H Kolk	45

About Gerrit‐Jan Weverling

Gerrit‐Jan Weverling is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Virology (350 citations), Infectious Diseases (622 citations) and Epidemiology (395 citations). Gerrit‐Jan Weverling has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Nicole H. T. M. Dukers–Muijrers, Jaap Goudsmit, John de Wit, Roel A. Coutinho, Maria Prins, Marco J. Bruno, Djuna L. Cahen, Paul Fockens, E RAUWS and K. Huibregtse. Their work appears in journals such as The Lancet, Gastroenterology and American Journal of Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact